Apple Health Outcome

Peptides for bmi

5 compoundsin Regimen’s catalog are configured to track bmi via Apple Health. Each one shows the dose range, listed benefits, and every outcome it’s set up to monitor. Tap through to plan a dose with the free reconstitution calculator.

BMI as a tracking proxy

Body mass index is a coarse derived metric — weight in kilograms divided by height in meters squared — used as a population-level screening tool. It does not distinguish lean from fat mass, but it remains the eligibility threshold for many weight-management medications (FDA labels for semaglutide and tirzepatide reference BMI ≥ 30, or ≥ 27 with comorbidities).

Because BMI is computed directly from height and weight, every compound that drives weight change will also move BMI. The number that matters clinically is the trajectory — a sustained downward slope is more meaningful than any single reading. Apple Health stores BMI alongside weight when you log either.

Compounds in Regimen tracked for bmi

5 compounds

Semaglutide

GLP-1 Receptor Agonist

GLP-1

A once-weekly GLP-1 receptor agonist for weight management and metabolic health.

  • Significant and sustained weight loss
  • Improved blood sugar regulation
  • Reduced cardiovascular risk markers

Tracks

WeightBMIAppetiteGlucose

Tirzepatide

GIP / GLP-1 Dual Agonist

GLP-1

A once-weekly dual GIP and GLP-1 receptor agonist delivering superior weight loss and metabolic improvements compared to GLP-1 monotherapy.

  • Greater average weight loss vs. semaglutide
  • Improved blood sugar control
  • Reduced appetite and cravings

Tracks

WeightBMIAppetiteGlucose

Liraglutide

GLP-1 Receptor Agonist (Saxenda / Victoza)

GLP-1

Daily injectable GLP-1 receptor agonist FDA-approved for type 2 diabetes (Victoza, up to 1.8 mg/day) and chronic weight management (Saxenda, up to 3.0 mg/day). Slows gastric emptying, increases satiety, improves glycemic control, and reduces cardiovascular events in T2D.

  • Sustained weight loss
  • A1C reduction in T2D
  • Appetite suppression and reduced food cravings

Tracks

WeightBMIAppetiteGlucose

Retatrutide

GIP / GLP-1 / Glucagon Triple Agonist

GLP-1

Tracks

WeightBMIAppetite

Cagrilintide

Long-Acting Amylin Analog

GLP-1

Tracks

WeightBMIAppetite

Frequently asked questions

Why does BMI matter for peptide protocols?

Insurance coverage and prescriber gatekeeping for GLP-1s typically reference BMI thresholds (≥ 30, or ≥ 27 with comorbidity, per the FDA label for semaglutide and tirzepatide). Tracking BMI alongside weight makes those documentation conversations easier and gives a single number for the PDF report you share with your prescriber.

Should I rely on BMI to judge whether a protocol is working?

BMI is fine as a proxy when body composition is roughly stable, but it can mislead when lean mass is changing. If you’re lifting weights on a GLP-1 protocol, weight may stall while body fat continues to fall — BMI will plateau even though the protocol is succeeding. Tracking body-fat percentage and waist circumference alongside BMI gives a fuller picture.

Related reading

Best peptide tracker app in 2026

An honest multi-protocol comparison of Regimen, PeptIQ, Shotsy, MeAgain, and the GLP-1 calculator apps.

Other outcomes